-
Medical students honored their outstanding mentors, professors, courses, and course directors at the annual Argus Awards Ceremony on Friday, Jan. 6.
-
Teresa Wilborn, Pharm.D., Ph.D., will serve as interim chair of the Department of Pharmacology and Toxicology, effective Jan. 1.
-
The UAB Heersink School of Medicine Office of Research introduces new faculty for Spring and Summer 2022. Please join Heersink School of Medicine and the Office of Research in welcoming these new faculty.
-
FASEB is the largest coalition of biological and biomedical research associations in the United States.
-
Teresa Wilborn, Pharm.D., Ph.D., professor and vice-chair in the Department of Pharmacology and Toxicology, has been awarded the 2022 Dean’s Excellence Award in Teaching.
-
Eighteen faculty members across Heersink School of Medicine’s departments have received 2022 Dean’s Excellence Awards in recognition of excellence in the areas of teaching, research, service, mentorship, and diversity.
-
The drug inhibits the kinase Cdk5, found in mature neurons. Cdk5 has long been implicated in neuropsychiatric and neurodegenerative conditions, but previous inhibitors have largely failed to reach the brain through the blood-brain barrier.
-
The American Cancer Society Board of Directors recognized UAB and its faculty’s commitment to further cancer research and promote health behaviors that can lessen cancer occurrence.
-
UAB’s research and reputation land it among the top institutions in the world.
-
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.